A24.9 Melioidosis, unspecified

Name of the Condition

• Melioidosis, unspecified

Summary

Melioidosis, unspecified, is an infectious disease caused by the bacterium Burkholderia pseudomallei. It can affect multiple organ systems and presents with a range of clinical manifestations, from localized infections to severe systemic illness. The condition is endemic in tropical regions and often linked to environmental exposure to contaminated soil or water.

Causes

Melioidosis is caused by Burkholderia pseudomallei, a gram-negative bacterium found in soil and water. Infection occurs through inhalation, ingestion, or skin inoculation of contaminated material. The bacteria can cause localized or disseminated disease depending on the route of exposure and the host's immune response.

Risk Factors

• Residing in or traveling to tropical regions where Burkholderia pseudomallei is endemic (e.g., Southeast Asia, northern Australia).
• Underlying conditions such as diabetes, chronic lung disease, or immunosuppression, which increase susceptibility to severe disease.
• High levels of environmental exposure (e.g., during floods or monsoons) that increase contact with contaminated soil or water.

Symptoms

• Fever and chills
• Muscle aches and joint pain
• Respiratory symptoms (e.g., cough, chest pain)
• Skin lesions or ulcers (localized form)
• Systemic signs of sepsis (e.g., shock, organ failure) in severe cases

Diagnosis

Diagnosis is based on clinical suspicion, exposure history, and laboratory testing. Confirmation may involve culturing Burkholderia pseudomallei from clinical specimens, such as blood, sputum, or wound swabs. Molecular testing (e.g., PCR) may also be used to detect the bacterium. Imaging studies may be performed to assess organ involvement.

Treatment Options

Treatment typically involves prolonged courses of antibiotics, such as ceftazidime or meropenem, followed by oral eradication therapy (e.g., trimethoprim-sulfamethoxazole) for several months. The specific regimen depends on the severity of the infection and the patient's clinical status. Supportive care, including management of sepsis or organ dysfunction, may be necessary in severe cases.

Prognosis and Follow-Up

Prognosis varies based on the severity of the infection and the patient's underlying health. Early diagnosis and appropriate treatment improve outcomes, but severe or disseminated disease can be fatal. Follow-up care includes monitoring for recurrence, especially in patients with chronic or relapsing infections, and managing any long-term complications.

Complications

• Sepsis or septic shock
• Multi-organ failure (e.g., liver, kidney, or respiratory)
• Chronic or relapsing infections
• Abscess formation in various organs

Lifestyle & Prevention

• Avoid contact with soil or water in endemic areas, especially during floods or heavy rainfall.
• Wear protective clothing (e.g., boots, gloves) when working in high-risk environments.
• Practice good wound care to prevent skin inoculation.
• Seek medical attention promptly if symptoms develop after potential exposure.

When to Seek Professional Help

Seek immediate medical care if you experience fever, respiratory distress, or signs of sepsis (e.g., confusion, low blood pressure) after potential exposure to Burkholderia pseudomallei, especially if you reside in or have traveled to an endemic region.

Tips for Medical Coders

Use code A24.9 for melioidosis when the condition is unspecified and no further detail is provided. Document the clinical presentation, exposure history, and diagnostic findings to support the code assignment. Ensure consistency with the patient's medical record and follow coding guidelines for infectious diseases.